DC Bead LUMI™ can be used as an embolic agent with or without delivery of doxorubicin or irinotecan. Unloaded DC Bead LUMI™ are intended to be used for the embolisation of non-malignant hypervascular tumours and arteriovenous malformations (AVMs).
For the use in malignant indications:
It is the doctor’s responsibility to give due consideration to the details in the drug product marketing authorisation in deciding which drug (either doxorubicin or irinotecan) to load DC Bead LUMI™ with and whether loading with that drug is appropriate for the patient under his/her care .The relevant Summary of Product Characteristics (SmPC) must be consulted. The type and dose of drug should also be assessed according to the individual patient’s clinical circumstances.
DC Bead and DC Bead LUMI are trademarks and/or registered trademarks of Biocompatibles UK Limited, a BTG International group company. Imagine where we can go, BTG and the BTG roundel logo are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks in the USA, the European Union and certain other territories. © 2017 Biocompatibles UK Ltd. EM-LUM-2017-0025. EMEA. Date of preparation January 2017.